Traditionally, FPG or OGTT have been useful in identifying patients with a GCK mutation within families or when choosing patients for genetic testing [14], but given that diagnostic criteria for diabetes are changing to place emphasis on HbA1c it was important to investigate this as an alternative measure. This evidence concerns the gene GCK and diabetes mellitus.